Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells

Neuropharmacology

Volumn 48, Issue 1, 2005, Pages 151-160

  Lee, Jin Koo ^a   Won, Je Seong ^a   Singh, Avtar K ^a,b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Adenosine; Adenosine kinase inhibitor; Adenosine receptor; C6 glioma cells; Inducible nitric oxide synthase

Indexed keywords

5' HYDROXYPYRAZOLO[3,4 D]PYRIMIDINE NUCLEOSIDE; 8 (3 CHLOROSTYRYL)CAFFEINE; ACRIFLAVINE; ADENOSINE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; CYCLIC AMP; FORSKOLIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITROBENZYLTHIOINOSINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GLIA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT;

ADENOSINE; ADENOSINE KINASE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOMA; INTERFERON TYPE II; L-LACTATE DEHYDROGENASE; LEUPEPTINS; LIPOPOLYSACCHARIDES; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROLINE; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RATS; THIOCARBAMATES; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11144262750     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.09.006     Document Type: Article

References (45)

1. L. Bo, T.M. Dawson, S. Wesselingh, S. Mork, S. Choi, P.A. Kong, D. Hanley, and B.D. Trapp Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains Annals of Neurology 36 1994 778 786
2. D.L. Boyle, E.A. Kowaluk, M.F. Jarvis, C.H. Lee, S.S. Bhagwat, M. Williams, and G.S. Firestein Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis Journal of Pharmacology and Experimental Therapeutics 296 2001 495 500
3. C. Brodie, P.M. Blumberg, and K.A. Jacobson Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells FEBS Letters 429 1998 139 142
4. C.C. Chen, J.K. Wang, W.C. Chen, and S.B. Lin Protein kinase C eta mediates lipopolysaccharide-induced nitric-oxide synthase expression in primary astrocytes Journal of Biological Chemistry 273 1998 19424 19430
5. H.B. Cottam, D.B. Wasson, H.C. Shih, A. Raychaudhuri, G. Di Pasquale, and D.A. Carson New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation Journal of Medicinal Chemistry 36 1993 3424 3430
6. B.N. Cronstein, D. Naime, and G. Firestein The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine Arthritis and Rheumatism 38 1995 1040 1045
7. A.H. Cross, T.P. Misko, R.F. Lin, W.F. Hickey, J.L. Trotter, and R.G. Tilton Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice Journal of Clinical Investigation 93 1994 2684 2690
8. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annual Review of Neuroscience 24 2001 31 55
9. G.S. Firestein, D. Boyle, D.A. Bullough, H.E. Gruber, F.G. Sajjadi, A. Montag, B. Sambol, and K.M. Mullane Protective effect of an adenosine kinase inhibitor in septic shock Journal of Immunology 152 1994 5853 5859
10. G.S. Firestein, D.A. Bullough, M.D. Erion, R. Jimenez, M. Ramirez-Weinhouse, J. Barankiewicz, C.W. Smith, H.E. Gruber, and K.M. Mullane Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins Journal of Immunology 154 1995 326 334
11. B.B. Fredholm, I.J. AP, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacological Reviews 53 2001 527 552
12. B.B. Fredholm, R.A. Cunha, and P. Svenningsson Pharmacology of adenosine A2A receptors and therapeutic applications Current Topics in Medicinal Chemistry 3 2003 413 426
13. J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends in Neuroscience 14 1991 60 67
14. S. Giri, N. Nath, B. Smith, B. Viollet, A.K. Singh, and I. Singh 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase Journal of Neuroscience 24 2004 479 487
15. V. Gavrilyuk, P. Horvath, G. Weinberg, and D.L. Feinstein A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells Journal of Neurochemistry 78 2001 129 140
16. D.G. Hardie, J.W. Scott, D.A. Pan, and E.R. Hudson Management of cellular energy by the AMP-activated protein kinase system FEBS Letters 546 2003 113 120
17. G. Hasko, and B.N. Cronstein Adenosine: an endogenous regulator of innate immunity Trends in Immunology 25 2004 33 39
18. G. Hasko, D.G. Kuhel, J.F. Chen, M.A. Schwarzschild, E.A. Deitch, J.G. Mabley, A. Marton, and C. Szabo Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms FASEB Journal 14 2000 2065 2074
19. K.K. Hwang, C.S. Hall, W.S. Spielman, and H.V. Sparks FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase European Journal of Pharmacology 425 2001 85 93
20. S.R. Jaffrey, and S.H. Snyder Nitric oxide: a neural messenger Annual Review of Cell and Developmental Biology 11 1995 417 440
21. M.F. Jarvis, H. Yu, S. McGaraughty, C.T. Wismer, J. Mikusa, C. Zhu, K. Chu, K. Kohlhaas, M. Cowart, C.H. Lee, A.O. Stewart, B.F. Cox, J. Polakowski, and E.A. Kowaluk Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor Pain 96 2002 107 118
22. J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection Annual Review of Pharmacology and Toxicology 41 2001 775 787
23. W.P. Luk, Y. Zhang, T.D. White, F.A. Lue, C. Wu, C.G. Jiang, L. Zhang, and H. Moldofsky Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition Journal of Neuroscience 19 1999 4238 4244
24. S. Majumdar, and B.B. Aggarwal Adenosine suppresses activation of nuclear factor-kappa B selectively induced by tumor necrosis factor indifferent cell types Oncogene 22 2003 1206 1218
25. L.P. Miller, L.A. Jelovich, L. Yao, J. DaRe, B. Ugarkar, and A.C. Foster Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats Neuroscience Letters 220 1996 73 76
26. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB Journal 6 1992 3051 3064
27. Z.H. Nemeth, S.J. Leibovich, E.A. Deitch, E.S. Vizi, C. Szabo, and G. Hasko cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine Journal of Pharmacology and Experimental Therapeutics 306 2003 1042 1049
28. K. Pahan, A.M. Namboodiri, F.G. Sheikh, B.T. Smith, and I. Singh Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes Journal of Biological Chemistry 272 1997 7786 7791
29. K. Pahan, F.G. Sheikh, A.M. Namboodiri, and I. Singh Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages Journal of Clinical Investigation 100 1997 2671 2679
30. K. Pahan, F.G. Sheikh, M. Khan, A.M. Namboodiri, and I. Singh Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes Journal of Biological Chemistry 273 1998 2591 2600
31. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
32. A. Poon, and J. Sawynok Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor European Journal of Pharmacology 384 1999 123 138
33. S. Rosengren, G.W. Bong, and G.S. Firestein Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage Journal of Immunology 154 1995 5444 5451
34. G.L. Stiles Adenosine receptors Journal of Biological Chemistry 267 1992 6451 6454
35. T. Tatlisumak, K. Takano, R.A. Carano, L.P. Miller, A.C. Foster, and M. Fisher Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion Stroke 29 1998 1952 1958
36. S.A. Trushin, K.N. Pennington, E.M. Carmona, S. Asin, D.N. Savoy, D.D. Billadeau, and C.V. Paya Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes Mol Cell Biol 23 2003 7068 7081
37. B.G. Ugarkar, A.J. Castellino, J.M. DaRe, J.J. Kopcho, J.B. Wiesner, J.M. Schanzer, and M.D. Erion Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues Journal of Medicinal Chemistry 43 2000 2894 2905
38. B.G. Ugarkar, J.M. DaRe, J.J. Kopcho, C.E. Browne 3rd, J.M. Schanzer, J.B. Wiesner, and M.D. Erion Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues Journal of Medicinal Chemistry 43 2000 2883 2893
39. Y.S. Wang, and T.D. White The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex Journal of Neurochemistry 72 1999 652 660
40. J.B. Wiesner, B.G. Ugarkar, A.J. Castellino, J. Barankiewicz, D.P. Dumas, H.E. Gruber, A.C. Foster, and M.D. Erion Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy Journal of Pharmacology and Experimental Therapeutics 289 1999 1669 1677
41. J.S. Won, J.K. Lee, and H.W. Suh Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells Brain Research Molecular Brain Research 89 2001 1 10
42. J.S. Won, Y.B. Im, L. Key, I. Singh, and A.K. Singh The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein Journal of Neuroscience 23 2003 7470 7478
43. J. Xaus, M. Mirabet, J. Lloberas, C. Soler, C. Lluis, R. Franco, and A. Celada IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation Journal of Immunology 162 1999 3607 3614
44. Q.W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase Journal of Biological Chemistry 269 1994 4705 4708
45. C.Z. Zhu, J. Mikusa, K.L. Chu, M. Cowart, E.A. Kowaluk, M.F. Jarvis, and S. McGaraughty A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats Brain Research 905 2001 104 110